학술논문

Respiratory Symptoms, Disease Burden, and Quality of Life in Australian Adults According to GOLD Spirometry Grades: Data from the BOLD Australia Study
Document Type
Academic Journal
Source
International Journal of Chronic Obstructive Pulmonary Disease. December 31, 2023, Vol. 18, p2839, 9 p.
Subject
Australia
United Kingdom
Language
English
ISSN
1178-2005
Abstract
Purpose: Population data on the burden of chronic obstructive pulmonary disease (COPD) are often based on patient-reported diagnoses of COPD, emphysema or chronic bronchitis, without spirometry. We aimed to investigate the relationship between health burden, quality of life and severity of airway obstruction in Australian adults aged [greater than or equal to] 40 years. Methods: We used data from the BOLD Australia study, which included randomly selected adults aged [greater than or equal to] 40 years from six study sites to reflect the sociodemographic and geographic diversity of the Australian population (n = 3522). Participants with post-bronchodilator airflow limitation (ratio of forced expiratory volume in 1 second [FEV.sub.1] to forced vital capacity Results: Of the study sample, 2969 participants did not have airflow limitation, 294 (8.4%) were classified as GOLD Grade 1, 212 (6.0%) as GOLD 2 and 43 (1.2%) as GOLD 3-4. Participants with higher GOLD grades had more respiratory symptoms, more comorbidities and greater burden than those with lower GOLD grades. The scores of mental and physical subscales of SF-12 were lower, indicating worse quality of life, from the no airflow limitation group to the GOLD 3-4 group (P = 0.03 and P < 0.001, respectively). Conclusion: Greater airflow limitation is associated with greater burden and poor quality of life. Interventions to prevent, or reduce the level of, airflow limitation will reduce the symptom burden and improve quality of life for patients. Keywords: chronic obstructive pulmonary disease, airflow limitation, comorbidities, The Burden of Obstructive Lung Disease, quality of life
Introduction Chronic obstructive pulmonary disease (COPD) is the most prevalent chronic respiratory disease that leads to a significant burden on health. (1) In 2017, COPD was the seventh leading cause [...]